Healey Center at Mass General Launches First ALS Platform Trial with Five Candidate Treatments

The Sean M. Healey & AMG Center at Mass General has chosen five “promising” candidate treatments from among 30 applications to test in its first platform trial for amyotrophic lateral sclerosis (ALS). The platform trial — a type of a clinical study that tests the efficacy of multiple therapies simultaneously — is designed to advance … Continue reading Healey Center at Mass General Launches First ALS Platform Trial with Five Candidate Treatments